MELBOURNE, AUSTRALIA--(Marketwire - November 01, 2007) - Prana Biotechnology Limited (NASDAQ: PRAN) (ASX: PBT), a biopharmaceutical company focused on the research and development of treatments for neurodegenerative disorders, today announced that it has closed an approximately A$8 million private placement with institutional and professional investors, a slightly larger amount than originally announced on September 12. The Company’s shareholders have authorized up to A$10 million in total funding, including the A$8 million already closed.
